NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Archive for 2018

MUE 09: Parkinson's Disease in Acute Care

Posted: September 05, 2018.
Category - Medicines Update Extra

 MUE 09: Parkinson's Disease in Acute Care

** This bulletin supersedes MUE 01 **

  • It is CRUCIAL NOT TO STOP Parkinson’s Disease (PD) medications for any significant length of time as there is a risk of neuroleptic malignant-like syndrome which may be fatal.
  • Ensure early referral to the PD team to minimise risk of medication administration problems.
  • When a patient does not have an individual supply of PD medication, supply should be sought immediately via the local main holding areas of PD medications across NHSGGC. Refer to NHSGGC guidance “PD medication stock list, acute hospitals” on StaffNet for details or contact pharmacy.
  • For nil by mouth (NBM) patients, alternative routes need to be considered immediately. Seek advice from a PD specialist. Refer to NHSGGC “PD NBM guidance” on StaffNet, clinical pharmacist or Medicines Information for clinical advice if PD specialists are unavailable.
  • In PD patients undergoing surgery, consider the full NBM period including pre-operative preparation, the total duration of surgery and post-operative recovery. Ensure advance planning where possible to avoid missed doses.
  • Co-careldopa (Duodopa®) intestinal gel must be continued in patients established on treatment. Refer to NHSGGC guidance “Duodopa Monograph for maintaining co-careldopa (Duodopa®) intestinal infusion treatment in patients admitted to hospital” on StaffNet for details.
  • Apomorphine must be continued in patients established on treatment. Refer to NHSGGC guidance “Apomorphine Subcutaneous Infusion Treatment in Patients Admitted to Hospital” on StaffNet for details.

Read More...

Formulary Update (August 2018)

Posted: August 20, 2018.
Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.

Read More...

Crohn’s Disease: Use of Biologics in Adults

Posted: August 17, 2018.
Category - Medicines Update

The NHSGGC guideline previously entitled ‘Anti Tumour Necrosis Factor Alpha Medications In Adult Crohn’s Disease’ has been reviewed and updated. This is now available on the Clinical Guideline Repository on Staffnet

Read More...

Name change from enoxaparin Becat® to Arovi®

Posted: August 17, 2018.
Category - Medicines Update

Name change from enoxaparin Becat® to Arovi® and availability of 120mg and 150mg pre-filled syringes Key points: Enoxaparin Becat® is changing its name to Arovi®....

Read More...

Dipyridamole MR Supply Issues

Posted: August 17, 2018.
Category - Medicines Update

Dipyridamole MR 200mg is currently subject to supply disruptions, with no definitive date as to when or if the situation will be resolved. Persantin Retard® (dipyridamole 200mg MR) has been discontinued by the manufacture...

Read More...

Prescribing Initiatives and Indicators

Posted: August 10, 2018.
Category - Medicines Update

Details of the 2018-19 prescribing initiative have been sent to GP practices.  To date 89% of GP practices (210/235) have committed to undertake the following six actions. This year’s initiative focuses on: Pre...

Read More...

Guideline News July 2018

Posted: August 10, 2018.
Category - Medicines Update

New Adult NHSGGC Guidelines now available on StaffNet

Read More...

Braltus® – risk of inhalation of capsule

Posted: July 17, 2018.
Category - Medicines Update

Braltus® is the preferred brand of tiotropium inhaler in GGC.  In May 2018, the MHRA issued a warning about the risk of inhalation of the capsules if placed in the mouthpiece of the Braltus® Zonda® inhaler device. &...

Read More...

Therapeutics Handbook Update July 2018

Posted: July 13, 2018.
Category - Medicines Update

The Adult Therapeutics Handbook content has now been updated and includes the following main changes: Resuscitation and anaphylaxis  The guideline on

Read More...

MU Extra - QT prolongation

Posted: July 13, 2018.
Category - Medicines Update

The Medicines Update Extra Bulletin on Drug induced QT prolongation has been updated. This consists of a

Read More...